Ocular Therapeutix
OCUL
$5.22
Share price
-11.01%
Change (1 day)
-8.99%
Change (1 year)
Categories
Revenue for Ocular Therapeutix (OCUL)
Revenue in 2023 (TTM): $58.44 M
According to Ocular Therapeutix's latest financial reports the company's current revenue (TTM) is $58.44 M. In 2022 the company made a revenue of $51.49 M an increase over the years 2021 revenue that were of $43.52 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ocular Therapeutix from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $58.44 M | 13.5% |
| 2022 | $51.49 M | 18.32% |
| 2021 | $43.52 M | 150.08% |
| 2020 | $17.4 M | 311.71% |
| 2019 | $4.22 M | 112.41% |
| 2018 | $1.99 M | 3.48% |
| 2017 | $1.92 M | 1.91% |
| 2016 | $1.88 M | 7.83% |
| 2015 | $1.75 M | 126.68% |
| 2014 | $0.77 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $0.13 B | 136.48% | 🇺🇸 USA |
 Anika Therapeutics ANIK | $0.16 B | 185.18% | 🇺🇸 USA |
 Intersect ENT XENT | $0.10 B | 82.66% | 🇺🇸 USA |
 Haemonetics HAE | $1.27 B | 2,073.40% | 🇺🇸 USA |